Marshall Wace, LLP Ionis Pharmaceuticals Inc Transaction History
Marshall Wace, LLP
- $78.4 Billion
- Q4 2024
A detailed history of Marshall Wace, LLP transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Marshall Wace, LLP holds 812,306 shares of IONS stock, worth $26.3 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
812,306
Previous 1,920,464
57.7%
Holding current value
$26.3 Million
Previous $76.9 Million
63.09%
% of portfolio
0.04%
Previous 0.1%
Shares
18 transactions
Others Institutions Holding IONS
# of Institutions
412Shares Held
140MCall Options Held
829KPut Options Held
789K-
Vanguard Group Inc Valley Forge, PA16.5MShares$532 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$458 Million0.31% of portfolio
-
Capital World Investors Los Angeles, CA11.5MShares$371 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$334 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.67MShares$280 Million0.06% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.59B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...